This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2020 Mar;70(2):78-85.

doi: 10.3322/caac.21599. Epub 2020 Feb 26.

Metastatic melanoma

Ragini R Kudchadkar¹, Michael C Lowe², Mohammad K Khan³, Stephanie M McBrien¹

Affiliations

Affiliations

¹ Department of Hematology/Oncology, Emory Winship Cancer Institute, Atlanta, Georgia.
² Department of Surgery, Emory Winship Cancer Institute, Atlanta, Georgia.
³ Department of Radiation Oncology, Emory Winship Cancer Institute, Atlanta, Georgia.

PMID: 32101327
DOI: 10.3322/caac.21599

Free article

Review

Metastatic melanoma

Ragini R Kudchadkar et al. CA Cancer J Clin. 2020 Mar.

Free article

. 2020 Mar;70(2):78-85.

doi: 10.3322/caac.21599. Epub 2020 Feb 26.

Authors

Ragini R Kudchadkar¹, Michael C Lowe², Mohammad K Khan³, Stephanie M McBrien¹

Affiliations

¹ Department of Hematology/Oncology, Emory Winship Cancer Institute, Atlanta, Georgia.
² Department of Surgery, Emory Winship Cancer Institute, Atlanta, Georgia.
³ Department of Radiation Oncology, Emory Winship Cancer Institute, Atlanta, Georgia.

PMID: 32101327
DOI: 10.3322/caac.21599

No abstract available

PubMed Disclaimer

Similar articles

Ground-glass opacity of the lung in a patient with melanoma: "The radiological seed of doubt".
Dalpiaz G, Kawamukai K, Parisi AM, La Torre L, Forcella D, Leuzzi G. Dalpiaz G, et al. Rev Esp Med Nucl Imagen Mol. 2015 Nov-Dec;34(6):390-2. doi: 10.1016/j.remn.2015.04.006. Epub 2015 Jun 3. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 26049663 English, Spanish. No abstract available.
Undifferentiated Sarcoma as Intermediate Step in Rhabdomyosarcomatous Transformation of a Metastatic Malignant Melanoma Resistant to Anti-BRAF Therapy: A Phenomenon Associated With Significant Diagnostic and Therapeutic Pitfalls.
Tran TAN. Tran TAN. Int J Surg Pathol. 2019 Sep;27(6):669-677. doi: 10.1177/1066896919839143. Epub 2019 Apr 3. Int J Surg Pathol. 2019. PMID: 30942107
[The gastrointestinal tract as the metastatic site of malignant epithelial tumors].
Madeya S, Börsch G. Madeya S, et al. Ergeb Inn Med Kinderheilkd. 1992;60:65-101. Ergeb Inn Med Kinderheilkd. 1992. PMID: 1582404 Review. German. No abstract available.
Prolonged untreated and treated course of a malignant melanoma.
Nashan D, Haufs MG, Kleinheinz J, Al-Dandashi C, Bruckner-Tuderman L. Nashan D, et al. Dermatology. 2006;212(1):93-5. doi: 10.1159/000089034. Dermatology. 2006. PMID: 16319486 No abstract available.
[Latest treatment strategy for pulmonary metastases in breast cancer].
Yoshizawa K. Yoshizawa K. Nihon Rinsho. 2002 May;60 Suppl 5:521-5. Nihon Rinsho. 2002. PMID: 12101726 Review. Japanese. No abstract available.

See all similar articles

Cited by

Pan-Cancer Analysis of ANO6 and Experimental Validation in Metastatic Melanoma.
An Y, Dong H, Yan M, Liu C, Hu D, Liu Q, Zhang J, Han X, Li Z, Xu M, Chen L, Zhang Q, Gao C. An Y, et al. Biochem Genet. 2025 Mar 5. doi: 10.1007/s10528-025-11074-7. Online ahead of print. Biochem Genet. 2025. PMID: 40042755
Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis.
Wu N, Sun H, Sun Q, Zhang F, Ma L, Hu Y, Cong X. Wu N, et al. BMC Cancer. 2023 May 8;23(1):414. doi: 10.1186/s12885-023-10891-6. BMC Cancer. 2023. PMID: 37158840 Free PMC article.
Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma.
Wang X, Ma S, Zhu S, Zhu L, Guo W. Wang X, et al. Biomedicines. 2025 Jan 17;13(1):225. doi: 10.3390/biomedicines13010225. Biomedicines. 2025. PMID: 39857808 Free PMC article. Review.
Long non-coding RNA CYTOR promotes the progression of melanoma via the miR-485-5p/GPI axis.
Lu H, Zhao Y, Zhang Y, Shi S, Hu H, Li X, Niu Y, Qi H, Ji S, Duan X, Liu Y. Lu H, et al. PeerJ. 2025 Apr 22;13:e19284. doi: 10.7717/peerj.19284. eCollection 2025. PeerJ. 2025. PMID: 40292095 Free PMC article.
Clinical and Molecular Correlates of NLRC5 Expression in Patients With Melanoma.
Lv L, Wei Q, Wang Z, Zhao Y, Chen N, Yi Q. Lv L, et al. Front Bioeng Biotechnol. 2021 Jul 9;9:690186. doi: 10.3389/fbioe.2021.690186. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34307322 Free PMC article.

See all "Cited by" articles

References

1. Sade-Feldman M, Yizhak K, Bjorgaard SL, et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell. 2019;176(1-2):404. doi:10.1016/j.cell.2018.12.034
1. Tawbi HA, Forsyth PA, Algazi A, et al. Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med. 2018;379:722-730.
1. Long GV, Atkinson V, Lo S, et al. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol. 2018;19:672-681.
1. Tawbi HAH, Forsyth PAJ, Hodi FS, et al. Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204) [abstract]. J Clin Oncol. 2019;37(15 suppl):9501.
1. Goldberg SB, Gettinger SN, Mahajan A, et al. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2016;17:976-983.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information